GSE117646
Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau
Alzheimer's disease (AD) is an age-associated neurodegenerative disease characterized by amyloidosis, tauopathy, and activation of microglia, the brain resident innate immune cells. We show that a RiboTag translational profiling approach can bypass biases due to cellular enrichment/cell sorting. In our recent study entitled “Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau”, we utilized data acquired using this approach in models of amyloidosis, tauopathy, and aging, to reveal a common set of alterations and identified a central APOE-driven network that converged on CCL3 and CCL4 across all conditions. Notably, examination of the aged female dataset demonstrated a significant exacerbation of many of these shared transcripts in this APOE network, revealing a potential mechanism for increased AD susceptibility in females. This study has broad implications for microglial transcriptomic approaches and provides new insights into microglial pathways associated with different pathological aspects of aging and AD. Overall design: Microglial transcriptomes from the forebrain were generated using RNAseq using an Illumina HiSeq 4000 were done for N=3-5 animals per condition in the context of aging, amyloidosis, tauopathy, and systemic inflammation (i.e. LPS or Poly(I:C) stimulation) in RiboTag mice. In addition, a cellular isolation procedure using enzymatic digestion and cell sorting was also used to compare this protocol versus RiboTag isolation during basal conditions and LPS induced inflammation.